ConnectTM is APLUSA’s proprietary enhanced qualitative approach of social media intelligence to create deeper links between what patients experience in their daily lives with the disease, and what physicians perceive from patients.
ESOPTM (Estimated Share of Preference) and Trade-off analysis:
Evaluate the likelihood of potential prescribers to seek to adopt new product formulations, or identify the impact of possible new product configurations on the marketplace, including increased strengths from prescriber and patient perspectives.
CongressTrackTM is an augmented evaluation of the impact of conferences including what physicians retained from various communications, what the impact of this is on their practice, and identifies the most memorable products.
- Examples of conferences in the scope : ASCO (American Society of Clinical Oncology), WCD (World Congress of Dermatology), EULAR (European League Against Rhumatism), EHA (European Hematology Association)
Voice-over-NumbersTM is a proprietary tool developped by APLUSA to enrich data collection with audio capture in the course of an on-line quantitative survey, to allow the respondent to provide deeper insights.
APLUSA created MEDataLAKE® to triangulate medical data with machine learning in accordance with GDPR and ethics. Beyond storage, the challenge is to be able to easily process and transform information to accelerate innovation cycles.